The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

med restart

Sep 20, 2006

I have an HIV positive friend who had been on Stocrin and Combivir until nine months ago, but stopped then. Now that she is considering to restart the meds, what regimen is best for her.

Response from Dr. Young

Thanks for your post.

The key issue for your friend is the conditions under which she stopped her regimen-- if the viral load was undetectable, this suggests that there wasn't significant drug resistance.

If this is the case, then resuming AZT/3TC (Combivir) and efavirenz (Stocrin, Sustiva) would be reasonable. That said, any time I initiate treatment in a patient, I'd recommend close clinical and laboratory monitoring, in order to make sure that things go according to plans.

Last, remember that efavirenz should be used with caution among women who might become pregnant, because of risk of birth defects in the child.

Best of health to you and your friend. BY

decision about meds now that Fortovase is not available
need help a.s.a.p.

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint